Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Peng

Showing results (391-400 of 909) with videos related to

Pageof 91
Sort By:
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 26, 2016
[Overview of CDISC standard and implementation in China]Victor Wu, Wen-Jun Bao, John Wang, et al.
Oncology Research and Treatment|February 3, 2022
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisLing Peng, Bao-Dong Qin, Song Xu, et al.
Frontiers in Immunology|March 4, 2022
The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell CancerHao Zeng, Fan Tong, Yawen Bin, et al.
Cancer Gene Therapy|April 4, 2022
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomasZhiqiang Wang, Liping Zhu, Kesang Li, et al.
Physiology and Molecular Biology of Plants : an International Journal of Functional Plant Biology|February 3, 2023
Transcriptome analyses reveal the effects of mixed saline-alkali stress on indoleacetic acid and cytokinins in <i>Malus hupehensis</i> Rehd. leavesXin-Liang Wang, Ling Peng, Jian Wang, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
Network and pathway-based analysis of candidate genes associated with esophageal adenocarcinomaJunfeng Li, Ling Peng, Hanbing Li, et al.
Pediatric Neurology|February 12, 2025
Clinical Features and Prognostic Factors of Pediatric Guillain-Barré Syndrome With Anti-Sulfatide AntibodyLa-Mei Chen, Juan Wang, Xiao-Ling Peng, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2021
Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancerXuetian Gao, Ling Peng, Li Zhang, et al.
American Journal of Translational Research|February 2, 2021
Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapyKesang Li, Suying Qian, Mengmeng Huang, et al.
Biomaterials|February 2, 2021
Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectivesQinghua Lyu, Ling Peng, Xiangqian Hong, et al.
Pageof 91

Showing results (391-400 of 909) with videos related to

Sort By:
Pageof 91
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 26, 2016
[Overview of CDISC standard and implementation in China]Victor Wu, Wen-Jun Bao, John Wang, et al.
Oncology Research and Treatment|February 3, 2022
Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-AnalysisLing Peng, Bao-Dong Qin, Song Xu, et al.
Frontiers in Immunology|March 4, 2022
The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell CancerHao Zeng, Fan Tong, Yawen Bin, et al.
Cancer Gene Therapy|April 4, 2022
Alternative splicing events in tumor immune infiltration in renal clear cell carcinomasZhiqiang Wang, Liping Zhu, Kesang Li, et al.
Physiology and Molecular Biology of Plants : an International Journal of Functional Plant Biology|February 3, 2023
Transcriptome analyses reveal the effects of mixed saline-alkali stress on indoleacetic acid and cytokinins in <i>Malus hupehensis</i> Rehd. leavesXin-Liang Wang, Ling Peng, Jian Wang, et al.
Journal of Gastrointestinal Oncology|March 14, 2023
Network and pathway-based analysis of candidate genes associated with esophageal adenocarcinomaJunfeng Li, Ling Peng, Hanbing Li, et al.
Pediatric Neurology|February 12, 2025
Clinical Features and Prognostic Factors of Pediatric Guillain-Barré Syndrome With Anti-Sulfatide AntibodyLa-Mei Chen, Juan Wang, Xiao-Ling Peng, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2021
Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancerXuetian Gao, Ling Peng, Li Zhang, et al.
American Journal of Translational Research|February 2, 2021
Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapyKesang Li, Suying Qian, Mengmeng Huang, et al.
Biomaterials|February 2, 2021
Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectivesQinghua Lyu, Ling Peng, Xiangqian Hong, et al.
Pageof 91